Literature DB >> 18493804

Pre-admission clinical course of meningococcal disease and opportunities for the earlier start of appropriate intervention: a prospective epidemiological study on 752 patients in the Netherlands, 2003-2005.

S C de Greeff1, H E de Melker, L M Schouls, L Spanjaard, M van Deuren.   

Abstract

To improve the timeliness of health care delivery to patients with meningococcal disease, the early disease evolution and clinical manifestation at admission were studied in all 752 patients with invasive meningococcal disease in the Netherlands in 2003-2005. Eighty-eight percent (88%) had serogroup B disease. The case fatality rate (CFR) was 6.7% overall, but reached 16% among adults over 50 years of age. The CFR was similar for serogroups B (6.3%) and C (5.2%). Admission followed 17 h (median) after the onset of symptoms. The CFR in patients admitted within 12 h, 12-18 h, 18-36 h or >36 h after the first symptoms was 10.2, 7.8, 3.5 and 2.2%, respectively. Only 60% of patients had skin lesions, and admission followed 2 h (median) later. Earlier recognition can be achieved when non-petechial clues are included in the diagnosis. A short duration of disease before admission is a simple tool in the recognition of patients with severe disease.

Entities:  

Mesh:

Year:  2008        PMID: 18493804     DOI: 10.1007/s10096-008-0535-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  29 in total

Review 1.  Meningococcal infections at the start of the 21st century.

Authors:  Petter Brandtzaeg; Marcel van Deuren
Journal:  Adv Pediatr       Date:  2005

2.  Underreporting of meningococcal disease incidence in the Netherlands: results from a capture-recapture analysis based on three registration sources with correction for false positive diagnoses.

Authors:  Sabine C de Greeff; Lodewijk Spanjaard; Jacob Dankert; Christian J P A Hoebe; Nico Nagelkerke; Hester E de Melker
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

Review 3.  Ascertainment of meningococcal disease in Europe.

Authors:  C Trotter; S Samuelsson; A Perrocheau; S de Greeff; H de Melker; S Heuberger; M Ramsay
Journal:  Euro Surveill       Date:  2005-12

4.  Anterior thigh pain or tenderness. A diagnostically useful manifestation of bacteremia.

Authors:  D B Louria; P Sen; R Kapila; E Johnson; L Smith; R Roberts
Journal:  Arch Intern Med       Date:  1985-04

5.  Prognosis of meningococcal septicaemia.

Authors:  J F Sinclair; C H Skeoch; D Hallworth
Journal:  Lancet       Date:  1987-07-04       Impact factor: 79.321

6.  High case-fatality rates of meningococcal disease in Western Norway caused by serogroup C strains belonging to both sequence type (ST)-32 and ST-11 complexes, 1985-2002.

Authors:  I Smith; D A Caugant; E A Høiby; T Wentzel-Larsen; A Halstensen
Journal:  Epidemiol Infect       Date:  2006-05-02       Impact factor: 2.451

7.  Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction.

Authors:  Caroline L Trotter; Nick J Andrews; Edward B Kaczmarski; Elizabeth Miller; Mary E Ramsay
Journal:  Lancet       Date:  2004 Jul 24-30       Impact factor: 79.321

8.  Some agent characteristics and their coexistence related to occurrence and severity of systemic meningococcal disease in Norway, Winter 1981-1982.

Authors:  K Bøvre; L O Frøholm; P Gaustad; E Holten; E A Høiby
Journal:  NIPH Ann       Date:  1983-06

9.  Extremity pain and refusal to walk in children with invasive meningococcal disease.

Authors:  Stanley H Inkelis; Daniel O'Leary; Vincent J Wang; Richard Malley; Martha K Nicholson; Nathan Kuppermann
Journal:  Pediatrics       Date:  2002-07       Impact factor: 7.124

10.  Case fatality of meningococcal disease in western Norway.

Authors:  A Halstensen; S H Pedersen; B Haneberg; B Bjorvatn; C O Solberg
Journal:  Scand J Infect Dis       Date:  1987
View more
  16 in total

Review 1.  Invasive meningococcal disease in the 21st century—an update for the clinician.

Authors:  Rachel Dwilow; Sergio Fanella
Journal:  Curr Neurol Neurosci Rep       Date:  2015-03       Impact factor: 5.081

2.  Experimental Evidence of Bacterial Colonization of Human Coronary Microvasculature and Myocardial Tissue during Meningococcemia.

Authors:  Jean Bergounioux; Mathieu Coureuil; Emre Belli; Mohamed Ly; Michelle Cambillau; Nicolas Goudin; Xavier Nassif; Olivier Join-Lambert
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

3.  Cost-effectiveness of vaccination against meningococcal B among Dutch infants: Crucial impact of changes in incidence.

Authors:  Koen B Pouwels; Eelko Hak; Arie van der Ende; Hannah Christensen; Germie P J M van den Dobbelsteen; Maarten J Postma
Journal:  Hum Vaccin Immunother       Date:  2013-02-13       Impact factor: 3.452

Review 4.  Meningococcal vaccination in pregnancy.

Authors:  Bahaa Abu Raya; Manish Sadarangani
Journal:  Hum Vaccin Immunother       Date:  2018-03-21       Impact factor: 3.452

5.  Meningococcal serogroup A, C, W₁₃₅ and Y conjugated vaccine: a cost-effectiveness analysis in the Netherlands.

Authors:  Hiltsje Hepkema; Koen B Pouwels; Arie van der Ende; Tjalke A Westra; Maarten J Postma
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

6.  Prevalence of Neoehrlichia mikurensis in ticks and rodents from North-west Europe.

Authors:  Setareh Jahfari; Manoj Fonville; Paul Hengeveld; Chantal Reusken; Ernst-Jan Scholte; Willem Takken; Paul Heyman; Jolyon M Medlock; Dieter Heylen; Jenny Kleve; Hein Sprong
Journal:  Parasit Vectors       Date:  2012-04-19       Impact factor: 3.876

7.  Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? experience from the Netherlands.

Authors:  Patricia Kaaijk; Arie van der Ende; Guy Berbers; Germie P J M van den Dobbelsteen; Nynke Y Rots
Journal:  BMC Infect Dis       Date:  2012-02-08       Impact factor: 3.090

8.  Adhesion of Neisseria meningitidis to dermal vessels leads to local vascular damage and purpura in a humanized mouse model.

Authors:  Keira Melican; Paula Michea Veloso; Tiffany Martin; Patrick Bruneval; Guillaume Duménil
Journal:  PLoS Pathog       Date:  2013-01-24       Impact factor: 6.823

9.  Prevalence and clinical course in invasive infections with meningococcal endotoxin variants.

Authors:  Gerwin D Rodenburg; Floris Fransen; Debby Bogaert; Kim Schipper; Rolf H H Groenwold; Hendrik Jan Hamstra; Brenda M Westerhuis; Diederik van de Beek; Peter van der Ley; Elisabeth A M Sanders; Arie van der Ende
Journal:  PLoS One       Date:  2012-11-29       Impact factor: 3.240

10.  The Burden of Infant Meningococcal Disease in the United States.

Authors:  R Judelsohn; G S Marshall
Journal:  J Pediatric Infect Dis Soc       Date:  2012-03-01       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.